4th Annual Mediclinic Middle East Research Conference
Hybrid event
Date : 27-28 May 2021
Timings : 27th 9am – 1pm I 28th 9am – 3pm


Our Mission

The UAE, with its dynamic leadership, has encouraged innovation in every field and medicine is very much at the top of this list. The meeting was initially designed to showcase, on an annual basis, the research undertaken by the physicians at Mediclinic Middle East and also by the MBRU students that they mentor. This has now evolved into a global clinical research presentation conference. The conference is open to all researchers around the world, but predominantly within the UAE, to present their work.

The Research Day has been successfully conducted with the collaboration of MBRU and this year it becomes a two day conference, with involvement of MBRU, UAEU, ADU and Fatma College. Prizes are awarded to poster and podium presenters with the top prize going to the best researcher of the year. This is to recognise the researchers and give them the opportunity to share their research and the findings, learnings and knowledge gained from these various research initiatives amongst their peers. The aim remains to encourage our medical professionals and students to actively take part or lead research initiatives for the advancement of medicine and to ultimately provide better, shorter, more effective and safer treatment protocols to patients in the UAE and beyond.


Chief Guest: H.E Dr. Jamal Mohammed Al Kaabi

Undersecretary, Department of Health, Abu Dhabi

His Excellency Dr. Jamal Mohammed Al Kaabi is the Undersecretary of the Department of Health, Abu Dhabi (DOH), having previously occupied prominent roles in Government operations following his experience in the military. Dr. Al Kaabi began his career in healthcare at HAAD (currently DOH), where he held the position of Section Head of Health Audit - Facilities, before being promoted to Head of Customer Services & Corporate Communications. In March 2014, Dr. Al Kaabi was appointed to work in the office of the Vice President of the Executive Council, as a consultant to the healthcare sector, before taking on the role of Director of Social Development at the Abu Dhabi Executive Council.

In July 2015, he moved to the General Secretariat of the Executive Council as Director of the Social Development Sector. Following this, in 2018, he was appointed Executive Director of Government Affairs. The following year, he served as Director General of the Abu Dhabi Executive Office. In February 2020, Dr. Al Kaabi moved to the Department of Finance (DOF), where he held the position of Director General of Governmental Affairs. In addition to his vast expertise in the government sector, Dr. Al Kaabi, presented a number of Arabic TV programmes. Dr. Al Kaabi is a graduate of UAE University with a bachelor's degree in Medicine and Surgery. He also holds a master's degree in Public Health and Leadership from Johns Hopkins Bloomberg School of Public Health in the United States of America.


Key Note Speaker: Dr. Alexandre Malouvier

Director of Global Data Strategy, Commercial & Strategic Healthcare & Technology Partnership, PRA Health Sciences, Paris, France

Alexandre Malouvier, PhD, MS, Sr Director Commercial & Strategic Healthcare & Technology Partnerships, Healthcare Intelligence and Innovation, has 20+ years of clinical research experience, the majority of which focused on real-world research and digital health. Dr. Malouvier holds a Ph.D. in Human Physiology, a Diploma of Statistics Applied to Clinical Research, and a Diploma in Bone Pathology from the University Paris VII-Denis Diderot, Paris, France. He also holds a Master in Bioengineering from the Universities of Rheims, France. In the past 20 years, Dr. Malouvier has specialized in late stage research, spending the last 16 years in departments or companies fully dedicated to peri- and post-approval programs. These included Compassionate-Use Programs (Expanded Access Programs, Named-Patient Programs), Post-Marketing Authorization Safety Studies (PASS), Post-Authorization Efficacy Studies (PAES), Drug-Utilization Studies (DUS) an many other observational research programs. His roles in leading project management offices in late phase research organizations has given him wide exposure to real world research from both the CRO and large pharma perspective and has cultivated his in-depth expertise. Dr Malouvier frequently authors white papers and makes presentations in professional forums.

Dr Malouvier is an active member of the Real-World Evidence Working Group of AFCROs (French association of CROs), the leader of EUCROF’s Real World Data and Digital Health Working Group. Dr Malouvier is a member of the Board of the University of Paris’s Fundamental Sciences and Biomedicine Faculty where he teaches clinical research. He is the co-creator of three courses, one for Clinical Research Associates, another for Medical Science Liaisons, and a Master Degree in Clinical Research and Translational Medicine.


Expert Speakers




Poster Awards


Dr. Edwin Hertzog's Award

Know about Mediclinic Research Campaign

Why You Should Join?


Great Lectures

Every year, the conference features outstanding lectures of superior quality. Join us to hear them espouse their research findings.


Research Excellence

The exposure to the evidence-based experimental approach to medical practice is a rare opportunity, not to miss.


Get Inspired

Get inspired to become a participant next year and join the community of researchers.



It's a wonderful platform to compete with peers on academic subjects


Pending Accreditation

Earn conference credit hours for completing the academic activity.



Be the one to utilize the Q&A opportunity in asking direct questions.

In Collaboration With